Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangements

Cancer Genetics and Cytogenetics

Volumn 170, Issue 2, 2006, Pages 115-120

  Madrigal, Irene ^a   Carrió, Ana ^a   Gómez, Cándida ^a   Rozman, María ^a   Esteve, Jordi ^a   Nomdedeu, Benet ^a   Campo, Elías ^a   Costa, Dolors ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBODY LABELING; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CENTROMERE; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHRONIC NEUTROPHILIC LEUKEMIA; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HEMATOLOGIC MALIGNANCY; HUMAN; LEUKEMIA; PRIORITY JOURNAL; TELOMERE;

CHROMOSOME ABERRATIONS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; GENE DUPLICATION; HEMATOLOGIC NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTO-ONCOGENES; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

BACTERIA (MICROORGANISMS);

EID: 33748964137     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.05.007     Document Type: Article

References (29)

1. Secker-Walker L.M., Mehta A., and Bain B. Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study. Br J Haematol 91 (1995) 490-501
2. Raynaud S., Baens M., Grosgeorge J., Rodgers K., Reid C., Dainton M., Dyer M., Fuzibet J.G., Gratecos N., Taillan B., Ayraud N., and Marynen P. Fluorescence in situ hybridization analysis of t(3;12)(q26;p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood 88 (1996) 682-689
3. Storlazzi C.T., Anelli L., Albano F., Zagaria A., Ventura M., Rocchi M., Panagopoulos I., Pannunzio A., Ottaviani E., Liso V., and Specchia G. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. Ann Hematol 83 (2004) 78-83
4. Reiter E., Greinix H., Rabitsch W., Keil F., Schwarzinger I., Jaeger U., Lechner K., Worel N., Streubel B., Fonatsch C., Mitterbauer G., and Kalhs P. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv(3)(q21q26) or homologous translocation t(3;3)(q21;q26). Ann Hematol 79 (2000) 374-377
5. Bartholomew C., Kilbey A., Clark A.M., and Walker M. The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation. Oncogene 14 (1997) 569-577
6. Kilbey A., and Bartholomew C. Evi-1 ZF1 DNA binding activity and a second distinct transcriptional repressor region are both required for optimal transformation of Rat1 fibroblasts. Oncogene 16 (1998) 2287-2291
7. Kreider B.L., Orkin S.H., and Ihle J.N. Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc Natl Acad Sci U S A 90 (1993) 6454-6458
8. Morishita K., Parker D.S., Mucenski M.L., Jenkins N.A., Copeland N.G., and Ihle J.N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54 (1988) 831-840
9. Morishita K., Parganas E., William C.L., Whittaker M.H., Drabkin H., Oval J., Taetle R., Valentine M.B., and Ihle J.N. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci U S A 89 (1992) 3937-3941
10. Suzukawa K., Parganas E., Gajjar A., Abe T., Takahashi S., Tani K., Asano S., Asou H., Kamada N., and Yokota J. Identification of a breakpoint cluster region 3′ of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 84 (1994) 2681-2688
11. Henzan H., Yoshimoto G., Okeda A., Nagasaki Y., Hirano G., Takase K., Tanimoto T., Miyamoto T., Fukuda T., Nagafuji K., and Harada M. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia. Ann Hematol 83 (2004) 784-788
12. Jolkowska J., and Witt M. The EVI-1 gene: its role in pathogenesis of human leukemias. [Review]. Leuk Res 24 (2000) 553-558
13. Mitani K., Ogawa S., Tanaka T., Miyoshi H., Kurokawa M., Mano H., Yazaki Y., Ohki M., and Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J 13 (1994) 504-510
14. Rubin C.M., Larson R.A., Anastasi J., Winter J.N., Thangavelu M., Vardiman J.W., Rowley J.D., and Le Beau M.M. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76 (1990) 2594-2598
15. Yufu Y., Sadamura S., Ishikura H., Abe Y., Katsuno M., Nishimura J., and Nawata H. Expression of EVI1 and the retinoblastoma genes in acute myelogenous leukemia with t(3;13)(q26;q13-14). Am J Hematol 53 (1996) 30-34
16. Langabeer S.E., Rogers J.R., Harrison G., Wheatley K., Walker H., Bain B.J., Burnett A.K., Goldstone A.H., Linch D.C., and Grimwade D. MRC Adult Leukaemia Working Party. EVI1 expression in acute myeloid leukaemia. Br J Haematol 112 (2001) 208-221
17. Barjesteh van Waalwijk van Doorn-Khosrovani S., Erpelinck C., van Putten W.L., Valk P.J., van der Poel-van de Luytgaarde S., Hack R., Slater R., Smit E.M., Beverloo H.B., Verhoef G., Verdonck L.F., Ossenkoppele G.J., Sonneveld P., de Greef G.E., Lowenberg B., and Delwel R. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101 (2003) 837-845
18. Vinatzer U., Mannhalter C., Mitterbauer M., Gruener H., Greinix H., Schmidt H.H., Fonatsch C., and Wieser R. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia. Genes Chromosomes Cancer 36 (2003) 80-89
19. In: Shaffer L.G., and Tommerup N. (Eds). ISCN 2005: an international system for human cytogenetic nomenclature (2005) (2005), S. Karger, Basel
20. Wieser R., Lechner K., Valent P., and Fonatsch C. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia. Haematologica 88 (2003) 1427-1429
21. Lahortiga I., Vazquez I., Agirre X., Larrayoz M.J., Vizmanos J.L., Gozzetti A., Calasanz M.J., and Odero M.D. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes Chromosomes Cancer 40 (2004) 179-189
22. Groupe Français de Cytogénétique Hématologique. Cytogenetic analysis in patients with primary myelodysplastic syndromes in leukaemic transformation: a report on 94 cases. Hematol Cell Ther 38 (1996) 177-181
23. Fleischman E.W., Volkova M.A., Fenkel M.A., Konstantinowa L.N., Kulagina O.E., Bavonov A.E., and Gordeeva A.A. Translocation (2;3)(p13;q26) in two cases of myeloid malignancies: acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia. Cancer Genet Cytogenet 87 (1996) 182-184
24. Kwong Y.L., Chan L.C., and Lie K.W. t(2;3)(p13;q26) in a case of chronic myeloid leukemia: importance of the involvement of 3q26. Cancer Genet Cytogenet 59 (1992) 95-96
25. Levaltier X., Penther D., Bastard C., and Troussard X. t(2;3)(p23;q26) in a patient with AML M2. Br J Haematol 94 (1996) 1027
26. Stevens-Kroef M., Poppe B., van Zelderen-Bhola S., van den Berg E., van der Blij-Philipsen M., Geurts van Kessel A., Slater R., Hamers G., Michaux L., Speleman F., and Hagemeijer A. Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features. Leukemia 18 (2004) 1108-1114
27. Iwase S., Furukawa Y., Horiguchi-Yamada J., Nemoto T., Takahara S., Kawano T., Sekikawa T., Ito K., Yamazaki Y., Kikuchi J., Morishita K., and Yamada H. A novel variant of acute myelomonocytic leukemia carrying t(3;12)(q26;p13) with characteristics of 3q21q26 syndrome. Int J Hematol 67 (1998) 361-368
28. Tosi S., Mosna G., Cazzaniga G., Giudici G., Kearney L., Biondi A., and Privitera E. Unbalanced t(3;12) in a case of juvenile myelomonocytic leukemia (JMML) results in partial trisomy of 3q as defined by FISH. Leukemia 11 (1997) 1465-1468
29. Gazzo S., Baseggio L., Coignet L., Poncet C., Morel D., Coiffier B., Felman P., Berger F., Salles G., and Callet-Bauchu E. Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma. Haematologica 88 (2003) 31-38